About Edward Goodwin
Form D filings for Biopharmaceutical Research from 2022 to 2023 list Edward Goodwin as director.
Edward Goodwin first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Edward Goodwin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Edward Goodwin works with at each company, as listed on that company's latest Form D.
Biopharmaceutical Research Co · Form D/A, Jun 20, 2023
GH
George Hodgin
Chief Executive Officer and director
CS
Charles Schumacher
Director